EUVIMEDEUVIMED entdecken
Crossref

Methotrexate gene polymorphisms link to toxicity but not pharmacokinetics in Chinese adults and adolescents with acute lymphoblastic leukemia

Hao Bing, Qixian Ling, Liping Liu, Jiamin Xu, Jian Gu, Libo Zhao

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2025.100181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Hao Bing und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Antimetabolites, Antineoplastic, Methotrexate, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Peking University Third Hospital, Peking University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-dose methotrexate (HD-MTX) is essential in treating acute lymphoblastic leukemia (ALL), but its pharmacokinetics and toxicity are influenced by transporter and metabolic enzyme gene polymorphisms. This study examines the impact of gene polymorphisms in the MTX metabolic pathway on toxicity and pharmacokinetics in Chinese patients with ALL to aid individualized therapy in order to ensure the safety of patients. We prospectively collected 273 serum MTX concentration data from 92 patients with ALL (15-71 years) undergoing HD-MTX. Differences in liver and kidney toxicity markers were analyzed across gene polymorphisms. A population pharmacokinetic model was developed using nonlinear mixed-effect modeling to explore the impact of demographic, biochemical, and genetic covariates. Patients who were homozygous for γ-glutamyl hydrolase gene rs13248452 (GG + AA genotypes) had higher urea levels. SLCO1B1 mutant allele carriers had elevated alanine aminotransferase and aspartate aminotransferase levels compared with homozygous patients. SLC19A1 rs2838957 CT genotype patients had significantly higher aspartate aminotransferase. Population pharmacokinetic analysis indicated that the glomerular filtration rate significantly affected the MTX clearance, whereas gene polymorphisms did not significantly alter the clearance rate or volume of distribution of MTX. In conclusion, gene polymorphisms in SLCO1B1, SLC19A1, and γ-glutamyl hydrolase correlate with MTX-induced alterations in liver and kidney function indicators, but the toxicity mechanisms may be independent of systemic pharmacokinetics. In clinical practice, dosage adjustments should be made based on glomerular filtration rate, with enhanced monitoring for high-risk genotypes. Genetic markers should be combined with renal function monitoring to optimize individualized MTX therapy and improve safety. SIGNIFICANCE STATEMENT: This study identifies γ-glutamyl hydrolase/SLCO1B1/SLC19A1 polymorphisms as key predictors of methotrexate toxicity in Chinese acute lymphoblastic leukemia patients, whereas population pharmacokinetic reveals glomerular filtration rate-not genetics-drives clearance. Findings advocate for genotype-toxicity monitoring and glomerular filtration rate-based dosing to improve safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimetabolites, AntineoplasticMethotrexatePrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultChinagamma-Glutamyl HydrolaseGenotypeGlomerular Filtration RateLiver-Specific Organic Anion Transporter 1Polymorphism, GeneticPolymorphism, Single NucleotideProspective StudiesReduced Folate Carrier ProteinEast Asian People

Stichwörter der Autor:innen

Acute lymphoblastic leukemiaGene polymorphismMethotrexatePopulation pharmacokineticsToxicity

Substanzen

Antimetabolites, Antineoplasticgamma-Glutamyl HydrolaseLiver-Specific Organic Anion Transporter 1MethotrexateReduced Folate Carrier ProteinSLC19A1 protein, humanSLCO1B1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Department of Pharmacy, Peking University People's Hospital, Beijing, China.
  • Department of Pharmacy, Peking University Third Hospital, Beijing, China. Electronic address: libozhao@bjmu.edu.cn.

Förderung

  • Peking University Third Hospital
  • Peking University

Zitieren

APA

Bing, H., Ling, Q., Liu, L., Xu, J., Gu, J., & Zhao, L. (2025). Methotrexate gene polymorphisms link to toxicity but not pharmacokinetics in Chinese adults and adolescents with acute lymphoblastic leukemia. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100181

Vancouver

Bing H, Ling Q, Liu L, Xu J, Gu J, Zhao L. Methotrexate gene polymorphisms link to toxicity but not pharmacokinetics in Chinese adults and adolescents with acute lymphoblastic leukemia. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100181

BibTeX
@article{Bing2025,
  author = {Bing, Hao and Ling, Qixian and Liu, Liping and Xu, Jiamin and Gu, Jian and Zhao, Libo},
  title = {Methotrexate gene polymorphisms link to toxicity but not pharmacokinetics in Chinese adults and adolescents with acute lymphoblastic leukemia},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2025.100181}
}
Kostenlos starten →